Vontobel Holding’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $691K | Buy |
5,464
+341
| +7% | +$43.1K | ﹤0.01% | 702 |
|
2025
Q1 | $655K | Buy |
5,123
+2,164
| +73% | +$277K | ﹤0.01% | 705 |
|
2024
Q4 | $391K | Buy |
2,959
+497
| +20% | +$65.7K | ﹤0.01% | 849 |
|
2024
Q3 | $358K | Buy |
2,462
+27
| +1% | +$3.93K | ﹤0.01% | 874 |
|
2024
Q2 | $334K | Sell |
2,435
-81
| -3% | -$11.1K | ﹤0.01% | 869 |
|
2024
Q1 | $345K | Sell |
2,516
-1,900
| -43% | -$261K | ﹤0.01% | 870 |
|
2023
Q4 | $600K | Sell |
4,416
-81
| -2% | -$11K | 0.01% | 749 |
|
2023
Q3 | $550K | Sell |
4,497
-2,877
| -39% | -$352K | 0.01% | 738 |
|
2023
Q2 | $936K | Buy |
7,374
+2,151
| +41% | +$273K | 0.01% | 615 |
|
2023
Q1 | $675K | Sell |
5,223
-2,588
| -33% | -$334K | 0.01% | 704 |
|
2022
Q4 | $1.03M | Buy |
7,811
+3,526
| +82% | +$463K | 0.01% | 575 |
|
2022
Q3 | $501K | Sell |
4,285
-1,441
| -25% | -$168K | 0.01% | 713 |
|
2022
Q2 | $674K | Buy |
5,726
+666
| +13% | +$78.4K | 0.01% | 637 |
|
2022
Q1 | $659K | Buy |
5,060
+440
| +10% | +$57.3K | 0.01% | 719 |
|
2021
Q4 | $705K | Buy |
4,620
+328
| +8% | +$50.1K | 0.01% | 722 |
|
2021
Q3 | $694K | Sell |
4,292
-9,467
| -69% | -$1.53M | 0.01% | 702 |
|
2021
Q2 | $2.25M | Buy |
13,759
+3,964
| +40% | +$649K | 0.02% | 411 |
|
2021
Q1 | $1.48M | Buy |
9,795
+7,395
| +308% | +$1.11M | 0.01% | 459 |
|
2020
Q4 | $364K | Buy |
+2,400
| New | +$364K | ﹤0.01% | 703 |
|